找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Aspects of Interferons; Michel Revel Book 1988 Kluwer Academic Publishers, Boston 1988 blood.brain tumors.cancer treatment.carcin

[復制鏈接]
查看: 26150|回復: 61
樓主
發(fā)表于 2025-3-21 20:03:01 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Clinical Aspects of Interferons
編輯Michel Revel
視頻videohttp://file.papertrans.cn/228/227789/227789.mp4
叢書名稱Developments in Medical Virology
圖書封面Titlebook: Clinical Aspects of Interferons;  Michel Revel Book 1988 Kluwer Academic Publishers, Boston 1988 blood.brain tumors.cancer treatment.carcin
出版日期Book 1988
關鍵詞blood; brain tumors; cancer treatment; carcinoma; cell; diseases; infection; infections; interferon; leukemia
版次1
doihttps://doi.org/10.1007/978-1-4613-1737-1
isbn_softcover978-1-4612-8977-7
isbn_ebook978-1-4613-1737-1
copyrightKluwer Academic Publishers, Boston 1988
The information of publication is updating

書目名稱Clinical Aspects of Interferons影響因子(影響力)




書目名稱Clinical Aspects of Interferons影響因子(影響力)學科排名




書目名稱Clinical Aspects of Interferons網(wǎng)絡公開度




書目名稱Clinical Aspects of Interferons網(wǎng)絡公開度學科排名




書目名稱Clinical Aspects of Interferons被引頻次




書目名稱Clinical Aspects of Interferons被引頻次學科排名




書目名稱Clinical Aspects of Interferons年度引用




書目名稱Clinical Aspects of Interferons年度引用學科排名




書目名稱Clinical Aspects of Interferons讀者反饋




書目名稱Clinical Aspects of Interferons讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-22 00:04:24 | 只看該作者
978-1-4612-8977-7Kluwer Academic Publishers, Boston 1988
板凳
發(fā)表于 2025-3-22 03:26:27 | 只看該作者
地板
發(fā)表于 2025-3-22 05:23:49 | 只看該作者
Interferon Therapy in Acute Viral Illnessesd spectrum of RNA and DNA viruses, but reports of its use in clinical trials of acute viral infections have been surprisingly meager. There are several reasons for this, the major one being that for the first 20 years after its discovery, stocks were in very short supply, and when available, very expensive.
5#
發(fā)表于 2025-3-22 11:36:36 | 只看該作者
Clinical Studies of Alpha and Gamma Interferons in Chronic Myelogenous Leukemiaeukemia (CML Ph’). The interferons examined are partially pure alpha interferon, followed by recombinant alpha A interferon (Roche), recombinant gamma interferon, and most recently, combinations of alpha and gamma interferons. Here we summarize what we consider to be the major concepts emerging from those trials.
6#
發(fā)表于 2025-3-22 13:35:59 | 只看該作者
Interferons in Breast Cancerriments showed a possible role for Interferons in treating malignant tumors, phase II trials were activated..A review of the clinical trials applied to the treatment of metastatic breast cancer does not demonstrate any efficiency of Interferon and furthers studies are required.
7#
發(fā)表于 2025-3-22 18:01:35 | 只看該作者
The Role of Beta Interferon in the Treatment of Cervical Dysplasiaby conservative procedures and tissue destruction methods are widely employed. Comparable or even better results in terms of complete remission are obtained with intra-perilesional injection of human fibroblast interferon. The efficacy of interferon is attributed to its antiviral, cytostatic and immunomodulatory properties.
8#
發(fā)表于 2025-3-22 23:17:25 | 只看該作者
The Return of the Symptom in the Postcolony,e recognized as desirable characteristics for use in reratory viral infections (1). In 1973 Merigan . showed that intranasal administration of human leukocyte interferon (HuIFN-α [Le]) in a total dosage of 14 Mu over 4 days reduced seroconversion and illness rates following experimental rhinovirus t
9#
發(fā)表于 2025-3-23 05:07:08 | 只看該作者
https://doi.org/10.1007/978-3-476-03986-6nt. The data to be analysed below suggest that, when properly used, interferon offers the combination of efficacy and safety that has not been achieved thus far by any of the other currently available treatments for these two viral infections. However, in order to put this analysis in its proper fra
10#
發(fā)表于 2025-3-23 09:30:53 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 17:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
建瓯市| 永康市| 海口市| 黄石市| 蓬莱市| 岑巩县| 扎赉特旗| 正镶白旗| 临沂市| 公主岭市| 江津市| 东港市| 阿克苏市| 宁化县| 永和县| 淳化县| 政和县| 井研县| 林口县| 武威市| 清镇市| 长岭县| 德昌县| 怀柔区| 湖南省| 阿图什市| 江阴市| 威远县| 宜宾县| 台北县| 泰顺县| 茶陵县| 石泉县| 井陉县| 芜湖县| 伊川县| 宽城| 和田县| 辽中县| 获嘉县| 云浮市|